MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Influence of age at onset on medication profile in patients with Parkinson’s disease: A prospective study from a tertiary care center in India

    VV. Holla, S. Prasad, T. Nagaraj, SGS. Bhat, M. Bhardwaj, DK. Samartha, SS. Nair, P. Mailankody, RR. Mahale, N. Kamble, R. Yadav, PK. Pal (Bengaluru, India)

    Objective: To study the effect of age at onset on the medication profile of various Parkinson's disease (PD) related medications. Background: Multiple factors determine the…
  • 2025 International Congress

    Therapeutic Effect and Mechanism of Targeted Nano-selenium in Mouse Model of Parkinson’s Disease Induced by MPTP

    W. Bi, L. Zhu, T. Chen, Y. Cen, J. Zou, Z. Su (Guangzhou, China)

    Objective: In the present study, we developed a nanozyme (Se@PB-ACPP) incorporating selenium-loaded Prussian blue (PB) and modified it with an activatable cell-penetrating peptide (ACPP) to…
  • 2025 International Congress

    Monitoring Parkinson’s Disease in the Dental Chair

    J. Schwartz, L. Dibenedetto, P. Engen, V. Ha, B. Killinger, C. Soto, S. Green, A. Naqvi, S. Tomar, M. Shaikh, M. Villanueva, D. Sanchez-Bass, C. Noh, R. Voigt, C. Goetz, A. Keshavarzian (Chicago, USA)

    Objective: Our goal is to bridge the mechanistic knowledge gap on the Microbiota-Gut-Oral-Brain-Axis (MGOBA)’s role in Parkinson’s disease (PD) pathogenesis through a case-control, proof-of-concept, observational…
  • 2025 International Congress

    iPad App-based Eye Tracking for the Early Detection of Parkinson’s Disease

    F. David, J. Koerner, E. Zou, J. Karl, C. Poon, C. Sodini, V. Sze, L. Verhagen-Metman, T. Heldt (Chicago, USA)

    Objective: Demonstrate the concurrent validity, diagnostic accuracy, and early detection ability of an iPad app-based eye tracking tool for the early detection of Parkinson’s disease…
  • 2025 International Congress

    Associations among blood biomarkers, clinical subtypes, and prognosis in Parkinson’s disease

    H. Oizumi, T. Hasegawa, I. Kawahata, T. Totsune, Y. Sugimura, T. Baba, H. Tanaka, T. Takahashi, M. Yoshioka, T. Sekimori, K. Fukunaga, A. Takeda (Sendai, Japan)

    Objective: The aim of the present study was to test whether plasma NF-L, FABP3, UCH-L1, and gray matter volumes can be used as prognostic biomarkers…
  • 2025 International Congress

    Salivary Biomarkers in Parkinson’s Disease: A Follow-Up Study

    MI. de Bartolo, D. Belvisi, E. Patricolo, M. Costanzo, C. Cutrona, F. Aiello, G. Leodori, A. Conte, G. Fabbrini, A. Berardelli, G. Vivacqua (Rome, Italy)

    Objective: Investigate longitudinal changes in salivary levels of oligomeric and total a-synuclein (a-syn), phosphorylated-tau (p-tau), total tau, MAP-LC3, and TNFa in Parkinson’s Disease (PD) patientsAssess…
  • 2025 International Congress

    Plasma neurofilament light chain in early Parkinson’ s disease predicts motor complications: A Prospective Cohort Study

    NN. Che (Chengdu, Sichuan, China)

    Objective: The current study aimed to identify risk plasma biomarkers in early-stage PD for future motor complications through a longitudinal Chinese PD cohort, which ultimately…
  • 2025 International Congress

    Prevalence and Management of Depression Among Parkinson’s Patient’s in an Outpatient Clinic Setting

    E. Parker, T. Siriwardena (Perth, Australia)

    Objective: To evaluate the prevalence of depression among Parkinson’s Disease (PD) patients attending an outpatient clinic and review current management to improve diagnosis and treatment…
  • 2025 International Congress

    Positive post-intervention effect of Biodanza therapy on inhibitory control related to the orbitomedial prefrontal cortex.

    M. Moreno, M. Aveiga, J. Guapisaca, G. Bueno, M. Pinos (CUENCA, Ecuador)

    Objective: A study was conducted to determine the effect of a Music-based-Movement (MbM) program on the physical and cognitive domains of a group of people…
  • 2025 International Congress

    Episodic Simulation in Parkinson’s Disease (PD)

    J. Decker, N. Hantke, E. Leonard (Portland, USA)

    Objective: Characterize episodic simulation capabilities in non-depressed, non-amnestic patients with PD compared to healthy controls using autobiographical interviewing techniques. Background: Cognitive decline in PD occurs…
  • « Previous Page
  • 1
  • …
  • 67
  • 68
  • 69
  • 70
  • 71
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley